Mercado global de deteção assistida por computador (CAD) – Tendências do setor e previsão para 2031

Análise e dimensão do mercado de deteção assistida por computador (CAD)

O mercado global de deteção assistida por computador (CAD) está a registar um crescimento significativo, impulsionado pela crescente prevalência de doenças crónicas como o cancro e pela crescente adoção de modalidades de imagem avançadas. Os sistemas CAD desempenham um papel crucial no aumento da precisão e eficiência da deteção de doenças, auxiliando os radiologistas e os profissionais de saúde na interpretação de imagens médicas. O mercado está também a ser impulsionado pelos avanços tecnológicos no software CAD, como a integração de inteligência artificial (IA) e algoritmos de aprendizagem automática, que permitem análises mais precisas e automatizadas de imagens médicas. Além disso, a crescente procura por diagnósticos precoces e precisos, juntamente com a crescente consciencialização dos benefícios dos sistemas CAD, está a alimentar o crescimento do mercado.

O tamanho do mercado global de deteção assistida por computador (CAD) foi avaliado em 896,26 milhões de dólares em 2023 e deverá atingir 1.852,45 milhões de dólares até 2031, com um CAGR de 9,5% durante o período de previsão de 2024 a 2031. Além dos insights sobre o mercado cenários como o valor de mercado, taxa de crescimento, segmentação, cobertura geográfica e grandes players, os relatórios de mercado com curadoria da Data Bridge Market Research também incluem análise especializada aprofundada, epidemiologia de pacientes, análise pipeline, análise de preços e estrutura regulatória.

Âmbito do relatório e segmentação de mercado       

Definição de mercado

A deteção assistida por computador (CAD) é uma tecnologia utilizada em imagens médicas que auxilia os radiologistas e outros profissionais de saúde na interpretação de imagens médicas, como raios X, ressonâncias magnéticas e tomografias computorizadas. Os sistemas CAD utilizam algoritmos para destacar áreas suspeitas ou anormalidades nas imagens, o que pode ajudar os profissionais de saúde a detetar possíveis sinais de doenças, como o cancro, de forma mais precisa e eficiente.                      

Dinâmica do mercado de deteção assistida por computador (CAD)

Motoristas

• Aumento da prevalência de doenças crónicas      

Os sistemas CAD desempenham um papel crucial na deteção e diagnóstico precoce destas doenças, levando a melhores resultados para os doentes. À medida que a população global envelhece e os estilos de vida se tornam mais sedentários, é expectável que a prevalência de doenças crónicas aumente, impulsionando a procura de sistemas CAD. Estes sistemas ajudam os profissionais de saúde a detetar anormalidades nas imagens médicas, permitindo uma intervenção precoce e melhorando os resultados do tratamento para os doentes. A crescente incidência de doenças crónicas, como o cancro e as doenças cardiovasculares, é um fator chave para o mercado da deteção assistida por computador.          

• Avanços tecnológicos nas modalidades de imagem

Os avanços tecnológicos nas modalidades de imagem, como a ressonância magnética, a tomografia computorizada e a mamografia, levaram a imagens de maior resolução, o que requer ferramentas de análise mais sofisticadas fornecidas pelo CAD. Por exemplo, os sistemas CAD podem analisar mamografias para detetar sinais precoces de cancro da mama que podem não ser visíveis a olho nu. À medida que a tecnologia de imagem continua a evoluir, espera-se que a procura por sistemas CAD aumente, impulsionando o crescimento do mercado. 

Oportunidades

• Foco na Telemedicina e Imagens Remotas      

Developing CAD systems tailored for telemedicine applications can expand market reach and improve access to healthcare in remote areas. CAD systems can enable healthcare providers to analyze medical images remotely, allowing for more efficient diagnosis and treatment planning. In addition, telemedicine can reduce the need for patients to travel long distances for medical consultations, improving patient convenience and reducing healthcare costs. The increasing adoption of telemedicine and remote imaging technologies presents opportunities for CAD manufacturers.              

• Investment in Research and Development    

Developing more advanced imaging technologies and analysis algorithms can enhance the performance of CAD systems and drive market growth. For example, researchers are exploring the use of AI and machine learning algorithms to improve the accuracy and efficiency of CAD systems. By investing in R&D, CAD manufacturers can stay ahead of the competition and meet the evolving needs of healthcare providers and patients. Continued investment in research and development (R&D) can drive innovation in CAD systems.

Restraints/Challenges

• High Cost of CAD Systems

The high cost of CAD systems is a significant barrier to adoption, particularly in developing regions where healthcare budgets are limited. The initial investment required for CAD systems, including the purchase of equipment, software, and training, can be prohibitive for some healthcare providers. Additionally, ongoing maintenance costs and the need for regular upgrades further contribute to the overall cost of CAD implementation. As a result, many healthcare facilities in developing regions may opt to forego computer aided detection systems or delay their adoption, limiting access to advanced diagnostic tools for patients in these areas.

• Limited Reimbursement Policies

Limited reimbursement policies for CAD procedures can hinder market growth by reducing the financial incentives for healthcare providers to invest in CAD systems. In many healthcare systems, reimbursement for CAD procedures may not adequately cover the cost of the technology, leading to financial losses for providers. As a result, healthcare facilities may be reluctant to invest in CAD systems or may limit their use to only those cases where reimbursement is guaranteed. This limited reimbursement can also deter manufacturers from developing new CAD technologies or expanding their market reach, further impeding market growth.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In March 2022, EDDA Technology signed an agreement with the Society of Interventional Oncology (SIO) for the Ablation with Confirmation of Colorectal Liver Metastases Prospective Trial for Microwave Ablation as a Local Cure (ACCLAIM)
• In November 2021, Fujifilm announced clinical trials for the REiLI Artificial Intelligence Platform, designed for the detection and diagnosis of intracranial hemorrhage and breast cancer

Computer Aided Detection (CAD) Market Scope

The computer aided detection (CAD) market is segmented on the basis of application, breast CAD imaging modalities, imaging modalities, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Application

• Breast Cancer
• Lung Cancer
• Colon/Rectal Cancer
• Prostate Cancer
• Liver cancer
• Bone Cancer
• Neurological/Musculoskeletal/Cardiovascular Cancer

Breast CAD Imaging Modalities

• Mammography
• Magnetic Resonance Imaging
• Ultrasound Imaging
• Tomosynthesis
• Nuclear Imaging

Imaging Modalities

• X-Ray Imaging
• Computed Tomography
• Ultrasound Imaging
• Magnetic Resonance
• Nuclear Medicine Imaging

End User

• Hospitals
• Diagnostic Centres
• Research Centres

Computer Aided Detection (CAD) Market Regional Analysis/Insights

The market is analyzed and market size insights and trends are provided by country, application, breast CAD imaging modalities, imaging modalities, and end user as referenced above.

The countries covered in the market are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.

North America is expected to dominate the market due to the region's increasing healthcare expenditure, which drives overall healthcare growth. The higher adoption of CAD for the diagnosis of cancer within North America contributes to its leading position in the market. The region's advanced healthcare infrastructure and strong emphasis on technological innovation further bolster the adoption of CAD systems.             

Asia-Pacific is expected to witness significant growth during the forecast period due to increasing awareness among patients regarding the importance of early detection of chronic diseases, coupled with promotional campaigns that emphasize the benefits of CAD systems in early diagnosis. The region's growing healthcare infrastructure and rising disposable incomes also play a key role in driving the adoption of CAD systems in Asia-Pacific.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.

Competitive Landscape and Computer Aided Detection (CAD) Market Share Analysis

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Some of the major players operating in the market are:

• EDDA Technology, Inc. (U.S.)
• FUJIFILM Holdings Corporation (Japan)
• Hologic, Inc. (U.S.)
• iCAD Inc. (U.S.)
• Koninklijke Philips N.V. (Netherlands)
• Siemens (Germany)
• CANON MEDICAL SYSTEMS CORPORATION (Japan)
• IBM (U.S.)
• Riverain Technologies (U.S.)
• Median Technologies (France)
• GENERAL ELECTRIC (U.S.)
• Shimadzu Analytical (India) Pvt. Ltd. (India)
• Carestream Health (U.S.)
• Hitachi Ltd. (Japan)
• SPA ESAOTE (Itália)
• Narayana Hrudayalaya Ltd (Índia)
• Karyopharm (EUA)

SKU-51959